Skip to main content
. 2018 Jun 29;16(3):2038–2045. doi: 10.3892/etm.2018.6370

Figure 1.

Figure 1.

Expression of miR-21 in NSCLC tissues. (A) Expression of miR-21 in tumor-adjacent normal tissues and NSCLC tissues. *P<0.05 compared with normal tissues. (B) Expression of miR-21 in NSCLC tissues from NSCLC patients without (N0) and with (N1) lymphatic metastasis. *P<0.05 compared with N0 group. (C) Expression of miR-21 in NSCLC tissues from patients at different clinical stages. *P<0.05 compared with patients at stages I/II. NSCLC, non-small cell lung cancer.